Maria Padilla, MD, Director of the Pulmonary Fibrosis and Interstitial Lung Disease Program, Professor, Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine
After completing her pulmonary fellowship at Mount Sinai School of Medicine and The Mount Sinai Medical Center, Dr. Padilla pursued her studies in lung transplantation by attending the programs at Toronto General Hospital and Stanford University. She was the co-founder of the program at The Mount Sinai Hospital in New York City. During her fellowship training, Dr. Padilla conducted research in pathology, developing models of pulmonary diseases under the mentorship of Dr. Jerome Kleinerman. She also participated in clinical research in Sarcoidosis and Interstitial Lung Diseases. She is a United Network for Organ Sharing (UNOS) certified transplant pulmonologist and a member of the International Society of Heart and Lung Transplantation (ISHLT). She served on the editorial and scientific advisory boards of the World Association of Sarcoidsosis and Other Granulomatous Diseases (WASOG). Dr. Padilla is a committee member of the Interstitial Lung Disease Network of the American College of Chest Physicians, and is also a steering committee member of the Pulmonary Fibrosis Indentification: Lessons for Optimizing Treatment (PILOT). She serves on the medical advisory boards of the Coalition for Pulmonary Fibrosis, the Sarcoidosis Research Foundation, the Hermansky Pudlak Syndrome Network, and the Scleroderma Foundation, Tri-State Chapter. She is a graduate of the Executive Leadership of American Medicine (ELAM) program.
Dr. Padilla specializes in the treatment of diffuse interstitial lung diseases, including idiopathic interstital pneumonia, acute interstital pneumonia, lymphocytic interstital pneumonia, non-specific interstital pneumonia, organizing pneumonia, bronchiollitis obliterans, and hypersensitivity pneumonia. She also specializes in lung diseases associated with rheumatologic disorders, such as scleroderma, rheumatoid arthritis, dermatomyositis, mixed connective tissue disease, and systemic lupus erythematosus. In addition, she also treats drug-induced lung disease, mycobacterial lung disease, Langerhans cell hystiocytosis, lymphangioleimyomatosis, pulmonary vasculitis, alveolar hemorrhage, and pulmonary alveolar proteinosis.
Mary Beasley, MD, Associate Professor, Pathology, Associate Professsor, Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine
Sakshi Dua, MD, Assistant Professor, Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine
Ioannis Tassiulas, MD, PhD, Department of Medicine, Division of Rheumatology